Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival

Małgorzata Mitura-Lesiuk1, Patrycja Najda2, Oliwia Rdzanek2

  • 1Department of Pediatric Hematology, Oncology and Transplantology, University Children's Hospital, Lublin, Poland.

Related Concept Videos